MarketsandMarkets http://www.marketresearch.com/marketsandmarkets-v3719/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm EST Fridays: 5:30am - 5:30pm EST Email: customerservice@marketresearch.com MarketResearch.com
GLOBAL DIAGNOSTIC ELECTROCARDIOGRAPH (ECG) MARKET By Product (Resting, Stress, Holter Monitor), by End-user (Hospitals, Home/Ambulatory, Research Center, Physician Office, Nursing Homes), by Lead Type (Single, 3-6, 12) Global Trends & Forecast to 2020 MarketsandMarkets sales@marketsandmarkets.com www.marketsandmarkets.com
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers fourteen industry verticals, including aerospace and defence, advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. Copyright 2014 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets. MarketsandMarkets 2
1 EXECUTIVE SUMMARY ECG devices enable doctors, physicians, and researchers to constantly monitor the heart rhythm for the diagnosis of known or suspected arrhythmias. The ECG devices segment is one of the most important segments in the cardiac monitoring market, owing to the increasing occurrences of lifestyle diseases and cardiovascular diseases globally. Government regulations in some countries also favor the use of ECGs in public places and by non-medical persons. Technological advancements like remote monitoring and ambulatory use of these devices for patient convenience and better compliance are also expected to spur the growth of this market. On the other hand, unsteady reimbursement policies and reducing reimbursement rates are factors that are expected to restrain the growth of this market. The global market for diagnostic ECG devices was valued at $ million in 2013 and is expected to reach $ million by 2020, growing at a CAGR of % from 2013 to 2020. FIGURE 1 MARKET SHARE ANALYSIS, BY PRODUCT TYPE, 2013 VS. 2020 % % % Resting % 2013 Stress 2020 % Holter % Source: Annual Reports, SEC Filings, Corporate Presentations, WHO, IJC, FDA, NIH, NHS, AHA, AAHFN, AJC, CDC, EMA, EDMA, ESC, Expert Interviews, and MarketsandMarkets Analysis MarketsandMarkets 3
Market Size ($Million) Global Diagnostic Electrocardiograph (ECG) Market 2 PREMIUM INSIGHTS 2.1 GLOBAL DIAGNOSTIC ECG MARKET FIGURE 2 GLOBAL DIAGNOSTIC ECG MARKET, 2011 2020 ($MILLION) 6,000 5,000 4,000 3,000 2,000 1,000-2011 2012 2013 2018 2020 Source: Annual Reports, SEC Filings, Corporate Presentations, WHO, IJC, FDA, NIH, NHS, AHA, AAHFN AJC, CDC, EMA, EDMA, ESC, Expert Interviews, and MarketsandMarkets Analysis MarketsandMarkets 4
3 MARKET OVERVIEW KEY FINDINGS The global diagnostic ECG market is expected to reach $ million by 2020, growing at a CAGR of % from 2013 to 2020 Various factors such as the increasing number of patients suffering from cardiovascular diseases (CVD) and the need for early diagnosis help to fuel the diagnostic ECG market The resting ECG systems segment accounted for the largest share of % of the global diagnostic ECG market Hospitals are the major end users of ECG devices, with a dominant share of % MarketsandMarkets 5
3.1 MARKET DYNAMICS 3.1.1 DRIVERS 3. 1. 1. 1 I n c r e as ing incid e n c e s o f lifestyle d iseases & c ar d iov ascu l ar d is e as e s The global diagnostic ECG market is primarily driven by increasing incidences of cardiovascular disease (CVD). CVD is the major cause of mortality worldwide, accounting for around % of all deaths. According to WHO estimates, since 2008, nearly million people across the globe have died of CVD and around million are estimated to die by 2030. Furthermore, the increasing number of lifestyle diseases, such as hypertension, obesity, dyslipidemia, and diabetes, also drive the diagnostic ECG market. According to WHO statistics, the global population of obese children under the age of five in 2012 was over million. Currently, more than % of people in the U.S. are obese, with in every people suffering from a heart condition. There is also a strong linear relationship between high blood pressure levels and the risk of developing CVD, as prehypertensives have a high risk of cardiovascular mortality. There is also a definite rise in the number of CVD cases in Asian countries, due to increasing sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking. Research shows almost a ninefold increase in cardiovascular diseases in India and China since the last decade. A study of heart disease conditions in Asia stated that the number of conditions would increase by over % by 2020 from 2012. The prevalence of prehypertension in India alone is estimated to be more than %, thus increasing the risk of CVD. This trend is expected to boost the growth of the diagnostic ECG market in this region. Thus, rising incidences of CVD is an impetus for the growth of the diagnostic ECG market worldwide. MarketsandMarkets 6
3.2 GLOBAL MARKET SHARE ANALYSIS 3.2.1 GLOBAL MARKET SHARE ANALYSIS FIGURE 3 GLOBAL DIAGNOSTIC ECG MARKET SHARE (VALUE), 2013 GE Healthcare Philips Mortara Schiller Welch Spacelabs Others Source: Annual Reports, SEC Filings, Corporate Presentations, Expert Interviews, and MarketsandMarkets Analysis In the global diagnostic ECG market, GE Healthcare accounted for the largest market share of % in 2013. This can be attributed to the company s large product portfolio of resting and stress ECG systems. GE Healthcare was followed by Philips and Mortara which accounted for % and % market shares, respectively, in 2013. The diagnostic ECG manufacturers in the others category accounted for a share of % and included companies such as Nihon Kohden (Japan), Cardionet (U.S.), and Mindray Medical (China), among others. MarketsandMarkets 7
4 GLOBAL DIAGNOSTIC ECG MARKET, BY PRODUCT 4.1 INTRODUCTION TABLE 1 GLOBAL DIAGNOSTIC ECG MARKET SIZE, BY PRODUCT, 2011 2020 ($MILLION) Product Type 2011 2012 2013 2018 2020 CAGR% (2013 2020) Resting ECG Systems Stress ECG Systems Holter Monitors Total Source: Annual Reports, SEC Filings, Corporate Presentations, WHO, IJC, FDA, NIH, NHS, AHA, AAHFN, AJC, EMA, EDMA, ESC, Expert Interviews, and MarketsandMarkets Analysis In terms of value, the resting ECG systems product segment accounted for the largest share of % of the global diagnostic ECG market in 2013. This segment was valued at $ million in 2013 and is expected to reach $ million by 2020, at a CAGR of % from 2013 to 2020. The growth of this segment can mainly be attributed to the increasing number of patients suffering from cardiac diseases as well as the low cost of the resting ECG technology in conjunction with many smart applications. MarketsandMarkets 8
4.2 RESTING ECG SYSTEMS Resting ECG systems monitor the heart activity during a person s resting period and are more widely used than stress ECG systems as they are simpler and faster methods to evaluate the heart s electrical activity. These systems cost only half as much as stress systems and are also more space-efficient as they do not require a treadmill or a bicycle. However, the market for these systems is gradually diminishing due to functional limitations when considering the parameters measured in resting ECG systems. Most basic type of resting system measures only a single parameter to evaluate the heart s electrical activity. More sophisticated systems measure as much as three to six parameters such as polarization, electrical activity, and heart rate. ECG devices such as Cardiovit AT-1 by Schiller are gaining popularity, especially in the primary care segment due to their easy-to-use functionalities as well as the quick and accurate 12-lead ECG analysis to detect subtle cardiac abnormalities. TABLE 2 RESTING ECG SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2011 2020 ($MILLION) Region 2011 2012 2013 2018 2020 CAGR% (2013 2020) North America Europe Asia-Pacific RoW Total Source: Annual Reports, SEC Filings, Corporate Presentations, WHO, IJC, FDA, NIH, NHS, AHA, AAHFN, AJC, EMA, EDMA, ESC, Expert Interviews, and MarketsandMarkets Analysis MarketsandMarkets 9
5 GLOBAL DIAGNOSTIC ECG MARKET, BY LEAD TYPE 5.1 INTRODUCTION TABLE 3 GLOBAL DIAGNOSTIC ECG MARKET SIZE, BY LEAD TYPE, 2011 2020 ($MILLION) Lead Type 2011 2012 2013 2018 2020 CAGR% (2013 2020) Single Lead 3 6 Lead 12 Lead Other Lead Total Source: Annual Reports, SEC Filings, Corporate Presentations, WHO, IJC, FDA, NIH, NHS, AHA, AAHFN, AJC, CDC, EMA, EDMA, ESC, Expert Interviews, and MarketsandMarkets Analysis In terms of value, the 3 6 type lead ECG devices segment was estimated at $ million in 2013 and is expected to reach $ million by 2020, growing at a CAGR of % from 2013 to 2020. Higher number of leads captures higher signals, thereby providing a detailed outlook. This makes it easier for providers to better interpret the electrical activity of the heart. Thus, 3 6 lead and 12-lead ECG device segments will grow at higher CAGRs than single lead ECG devices. MarketsandMarkets 10
Market Size ($Million) Market Size ($Million) Market Size ($Million) Market Size ($Million) Global Diagnostic Electrocardiograph (ECG) Market 6 GLOBAL DIAGNOSTIC ECG MARKET, GEOGRAPHICAL ANALYSIS 6.1 INTRODUCTION The diagnostic electrocardiograph (ECG) market is predominantly divided into four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The global diagnostic ECG market was valued at $ million in 2013 and is expected to reach $ million by 2020, at a CAGR of %. North America accounted for the largest share of % of the diagnostic ECG market in 2013. FIGURE 4 DIAGNOSTIC ECG MARKET, GEOGRAPHICAL ANALYSIS, BY PRODUCT 2011 2020 ($MILLION) 250 200 150 RoW 1,000 800 600 North America 100 400 50 0 Resting Stress Holter 200 0 Resting Stress Holter North America Europe APAC ROW 600 500 400 300 200 APAC 600 500 400 300 200 Europe 100 0 Resting Stress Holter 100 0 Resting Stress Holter Source: Annual Reports, SEC Filings, Corporate Presentations, WHO, IJC, FDA, NIH, NHS, AHA, AAHFN AJC, CDC, EMA, EDMA, ESC, Expert Interviews, and MarketsandMarkets Analysis MarketsandMarkets 11
7 COMPETITIVE LANDSCAPE FIGURE 5 PERCENTAGE DISTRIBUTION OF KEY GROWTH STRATEGIES OF THE GLOBAL DIAGNOSTIC ECG MARKET, 2011 2014 xx xx xx xx New Product Launches Agreements, Partnerships and Collaborations Expansions xx Mergers & Acquisitions Others Source: Annual Reports, SEC Filings, and Corporate Presentations MarketsandMarkets 12
Total Revenue ($Million) R&D Intensity (%) Global Diagnostic Electrocardiograph (ECG) Market 8 COMPANY PROFILES 8.1 GE HEALTHCARE 8.1.1 COMPANY SNAPSHOT Company at a Glance Recent Financials 2013 Founded: 2004 Headquarters: U.K. No. of Employees: Revenue: $ Million R&D Expenditure: % of Total Sales Ownership: Public, NYSE: GE 149,500 149,000 148,500 148,000 147,500 147,000 146,500 146,000 145,500 145,000 144,500 2010 2011 2012 2013 3.5% 3.0% 2.5% 2.0% 1.5% 1.0% 0.5% 0.0% Total Revenue ($Million) R&D Intensity (%) Geographic Revenue Mix U.S Pacific Basin Europe Middle East and Africa The Americas Business Revenue Mix GE Capital Power & Water Aviation Healthcare Oil & Gas Appliances & Lighting Energy Management Transport Source: SEC Filings, Annual Reports, and Corporate Presentations MarketsandMarkets 13
8.1.2 SWOT STRENGTHS Skilled workforce, experienced business units, strong distribution and sales network Strong financial position leading to rising R&D investments to strengthen the ECG products portfolio Continued innovation in diagnostic cardiology monitoring resulting in development of novel products Flux in the regulatory environment including lack of clarity, changing rules, and uncertain timelines Fluctuating currencies and economic instability in developed countries S T W GE HEALTHCARE O Voluntary product recalls FDA warning letters for use of malfunctioned medical device Dependence on third parties for raw materials Growing geriatric population Untapped markets of emerging economies Rising incidences of cardiovascular diseases Technological advancements Inorganic growth strategies WEAKNESSES THREATS OPPORTUNITIES Source: MarketsandMarkets Analysis MarketsandMarkets 14
Disclaimer: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customers internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets' research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to noncustomers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited. For information regarding permission, contact: Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets 15